Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia: data from the PedNet cohort
Marloes S de Kovel,Carmen Escuriola-Ettingshausen,Christoph Königs,Susanna Ranta,Kathelijn Fischer,PedNet Study Group,M T Alvarèz Román,O Benitez Hidalgo,J Blatny,M Bührlen,M Carvalho,H Chambost,A Rosa Cid,C Oudot,C Escuriola-Ettingshausen,K Fischer,C Van Geet,H Glosli,N Gretenkort Andersson,R Ljung,C Königs,M Koskenvuo,C Male,T Stamm Mikkelsen,A Molinari,J Motwani,B Nolan,R d'Oiron,J Oldenburg,M Olivieri,H Pergantou,F Pinto,S Ranta,M Kartal-Kaess,E Zápotocká,G Kenet,M Carcao,G Rivard
DOI: https://doi.org/10.1016/j.jtha.2024.05.030
Abstract:Background: Information on bleeding phenotype in nonsevere hemophilia may be used to determine target factor levels for prophylaxis or gene therapy in severe hemophilia. Objectives: To assess the association between endogenous factor level and bleeding phenotype in children with nonsevere (factor [F]VIII/FIX activity 1%-25%) hemophilia A (HA) and B without prophylaxis. Methods: Data on annualized bleeding rate (ABR), annualized joint bleeding rate (AJBR), and onset of bleeding were extracted from the international PedNet cohort including children born since 2000. Mean ABR and AJBR were modeled and compared according to FVIII/FIX endogenous activity (1%-2%, 3%-5%, 6%-10%, 11%-15%, 16%-20%, and 21%-25%) using negative binomial regression. Onset of bleeding was analyzed using Kaplan-Meier survival curves. Results: Eight hundred twenty-five children (40% with moderate hemophilia; 87% with HA) with median follow-up of 7.4 years/child were included. The median age at onset of bleeding and median bleeding rates changed with increasing endogenous activity. From endogenous FVIII 1% to 2% to 21% to 25%, the age at onset of bleeding changed from a median of 1.4 to 14.2 years, ABR from 1.6 to 0.1/y, and AJBR from 0.5 to 0.0/y. From endogenous FIX 1% to 2% to 16% to 25%, the onset of bleeding changed from a median of 1.7 to 6.1 years, ABR from 0.5 to 0.1/y, and AJBR from 0.1 to 0.0/y. The negative correlation between AJBR and factor level was most strongly pronounced up to a factor level of 6% in HA and hemophilia B. Conclusion: Endogenous factor activity of >5% was identified as a threshold to significantly lower joint bleeding rate, while FVIII levels >15% and FIX levels >10% were sufficient to achieve the goal of 0 bleeds in this pediatric cohort.